Awakn Life Sciences Stock Performance

AWKNF Stock  USD 0.09  0.01  7.84%   
On a scale of 0 to 100, Awakn Life holds a performance score of 5. The firm shows a Beta (market volatility) of -3.31, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Awakn Life are expected to decrease by larger amounts. On the other hand, during market turmoil, Awakn Life is expected to outperform it. Please check Awakn Life's value at risk, rate of daily change, and the relationship between the total risk alpha and expected short fall , to make a quick decision on whether Awakn Life's price patterns will revert.

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Awakn Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Awakn Life reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow366.1 K
Total Cashflows From Investing Activities-1.7 M
  

Awakn Life Relative Risk vs. Return Landscape

If you would invest  10.00  in Awakn Life Sciences on August 25, 2024 and sell it today you would lose (0.51) from holding Awakn Life Sciences or give up 5.1% of portfolio value over 90 days. Awakn Life Sciences is currently producing 0.9202% returns and takes up 14.4096% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Awakn, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Awakn Life is expected to generate 18.75 times more return on investment than the market. However, the company is 18.75 times more volatile than its market benchmark. It trades about 0.06 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of risk.

Awakn Life Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Awakn Life's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Awakn Life Sciences, and traders can use it to determine the average amount a Awakn Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0639

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsAWKNF
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 14.41
  actual daily
96
96% of assets are less volatile

Expected Return

 0.92
  actual daily
18
82% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
5
95% of assets perform better
Based on monthly moving average Awakn Life is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Awakn Life by adding it to a well-diversified portfolio.

Awakn Life Fundamentals Growth

Awakn OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Awakn Life, and Awakn Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Awakn OTC Stock performance.

About Awakn Life Performance

By analyzing Awakn Life's fundamental ratios, stakeholders can gain valuable insights into Awakn Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Awakn Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Awakn Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. Awakn Life is traded on OTC Exchange in the United States.

Things to note about Awakn Life Sciences performance evaluation

Checking the ongoing alerts about Awakn Life for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Awakn Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Awakn Life Sciences is way too risky over 90 days horizon
Awakn Life Sciences has some characteristics of a very speculative penny stock
Awakn Life Sciences appears to be risky and price may revert if volatility continues
Awakn Life Sciences has high likelihood to experience some financial distress in the next 2 years
Awakn Life Sciences has accumulated 1.62 M in total debt with debt to equity ratio (D/E) of 1.13, which is about average as compared to similar companies. Awakn Life Sciences has a current ratio of 0.45, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Awakn Life until it has trouble settling it off, either with new capital or with free cash flow. So, Awakn Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Awakn Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Awakn to invest in growth at high rates of return. When we think about Awakn Life's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 236.04 K. Net Loss for the year was (15.95 M) with loss before overhead, payroll, taxes, and interest of (276.83 K).
Awakn Life Sciences has accumulated about 481.83 K in cash with (8.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Evaluating Awakn Life's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Awakn Life's otc stock performance include:
  • Analyzing Awakn Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Awakn Life's stock is overvalued or undervalued compared to its peers.
  • Examining Awakn Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Awakn Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Awakn Life's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Awakn Life's otc stock. These opinions can provide insight into Awakn Life's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Awakn Life's otc stock performance is not an exact science, and many factors can impact Awakn Life's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Awakn OTC Stock analysis

When running Awakn Life's price analysis, check to measure Awakn Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Awakn Life is operating at the current time. Most of Awakn Life's value examination focuses on studying past and present price action to predict the probability of Awakn Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Awakn Life's price. Additionally, you may evaluate how the addition of Awakn Life to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance